MAVS Human Pre-designed siRNA Set A
Based on 1 publication(s) in Google Scholar
MAVS Human Pre-designed siRNA Set A contains three designed siRNAs for MAVS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) MAVS Human Pre-designed siRNA Set A
More
Activité biologique
Description
MAVS Human Pre-designed siRNA Set A contains three designed siRNAs for MAVS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Components
MAVS siRNA-1: 5 nmol (HPLC)
MAVS siRNA-2: 5 nmol (HPLC)
MAVS siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
Gene ID
Gene Information
MAVS - mitochondrial antiviral signaling protein Gene (Human)
Also Known as
IPS1; VISA; IPS-1; CARDIF
Chemical Information
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
bioRxiv
ARID1A deficiency unleashes centromeric RNA transcription to drive chromosomal instability and boosts PKMYT1 inhibitor efficacy via RNA sensing. [Abstract]2026 Apr 13:2026.04.11.717899. PMID: 42039593
Protocole
-
RNA interference technology
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing gene transcription or activating RNA degradation. This mechanism was discovered in plants in 1998 by Andrew Fire and Craig Mello. Today, this phenomenon can be observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals.
Pureté et documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)